Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Monoclonal antibodies, such as panitumumab, can block tumor growth in different
ways. Some block the ability of tumor cells to grow and spread. Other find tumor cells and
help kill them or carry tumor-killing substances to them. Giving panitumumab together with
paclitaxel and carboplatin may be a better way to block tumor growth.
PURPOSE: This phase II trial is studying the side effects and how well paclitaxel and
carboplatin together with panitumumab works in treating patients with metastatic triple
negative breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences